Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction.

MLA

van Minkelen, Rick, et al. “Haplotypes of the Interleukin-1 Receptor Antagonist Gene, Interleukin-1 Receptor Antagonist MRNA Levels and the Risk of Myocardial Infarction.” Atherosclerosis, vol. 203, no. 1, Mar. 2009, pp. 201–05. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2008.06.029.

APA

van Minkelen, R., Wettinger, S. B., de Visser, M. C. H., Vos, H. L., Reitsma, P. H., Rosendaal, F. R., Bertina, R. M., & Doggen, C. J. M. (2009). Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis, 203(1), 201–205. https://doi.org/10.1016/j.atherosclerosis.2008.06.029

Chicago

van Minkelen, Rick, Stephanie Bezzina Wettinger, Marieke C H de Visser, Hans L Vos, Pieter H Reitsma, Frits R Rosendaal, Rogier M Bertina, and Carine J M Doggen. 2009. “Haplotypes of the Interleukin-1 Receptor Antagonist Gene, Interleukin-1 Receptor Antagonist MRNA Levels and the Risk of Myocardial Infarction.” Atherosclerosis 203 (1): 201–5. doi:10.1016/j.atherosclerosis.2008.06.029.